STOCK TITAN

Pulmonx to Present at the Bank of America Securities 2022 Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Pulmonx Corporation (Nasdaq: LUNG), a leader in minimally invasive treatments for severe lung disease, will present at the Bank of America Securities 2022 Healthcare Conference on May 10, 2022, at 12:40 PM PT. A live and archived webcast will be available on the company's investor website. Pulmonx is known for its innovative Zephyr Valve, which treats patients with severe emphysema/COPD and has received FDA breakthrough device designation. The valve is commercialized in over 25 countries, with more than 100,000 units used to date.

Positive
  • None.
Negative
  • None.

REDWOOD CITY, Calif., April 26, 2022 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced the company will present at the upcoming Bank of America Securities 2022 Healthcare Conference in Las Vegas. Management is scheduled to present on Tuesday, May 10, 2022, at 12:40 PM PT / 3:40 PM ET.

A live and archived webcast of the presentation will be available on “Investors” section of the Pulmonx website at https://investors.pulmonx.com/.

About Pulmonx Corporation
Pulmonx Corporation (Nasdaq: LUNG) is a global leader in minimally invasive treatments for severe lung disease. Pulmonx’s Zephyr® Endobronchial Valve, Chartis® Pulmonary Assessment System and StratX® Lung Analysis Platform are designed to assess and treat patients with severe emphysema/COPD who despite medical management are still profoundly symptomatic. Pulmonx received FDA pre-market approval to commercialize the Zephyr Valve following its designation as a “breakthrough device.” The Zephyr Valve is commercially available in more than 25 countries, with over 100,000 valves used to treat more than 25,000 patients. For more information on the Zephyr Valves and the company, please visit www.Pulmonx.com.

Pulmonx®, Chartis®, StratX®, and Zephyr® are registered trademarks of Pulmonx Corporation.

Contact
Brian Johnston
Gilmartin Group
investors@pulmonx.com

 


FAQ

When will Pulmonx Corporation present at the Bank of America Securities 2022 Healthcare Conference?

Pulmonx Corporation is scheduled to present on May 10, 2022, at 12:40 PM PT.

What is the ticker symbol for Pulmonx Corporation?

The ticker symbol for Pulmonx Corporation is LUNG.

Where can I watch the presentation by Pulmonx Corporation?

You can watch the live and archived webcast of the presentation on Pulmonx's investor website.

What products does Pulmonx Corporation offer for lung diseases?

Pulmonx offers the Zephyr Endobronchial Valve, Chartis Pulmonary Assessment System, and StratX Lung Analysis Platform.

How many countries is the Zephyr Valve commercially available in?

The Zephyr Valve is commercially available in more than 25 countries.

Pulmonx Corporation

NASDAQ:LUNG

LUNG Rankings

LUNG Latest News

LUNG Stock Data

236.93M
37.60M
4.98%
94.91%
2.13%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
REDWOOD CITY